SUBSCRIBE
SUBSCRIBE
News   Policy

US FDA Panel Backs New Johnson & Johnson (JOBS) Hip Implant

August 19, 2009 | 
1 min read
Bookmark and Share

Reuters -- Johnson & Johnson won a U.S. advisory panel's support on Tuesday for a novel hip replacement designed to provide more durability than current implants.
Regulatory
Johnson & Johnson Family of Companies
MORE ON THIS TOPIC
FDA
Novo’s turnaround plan, weight loss wins, Ultragenyx’s Sanfilippo approval, IPO blitz
September 23, 2026
 · 
2 min read
 · 
Jef Akst
Illustration showing businessman trying to create his own road
FDA
Compass vows to press on with FDA application despite new trial request
September 22, 2026
 · 
3 min read
 · 
Annalee Armstrong
FDA
FDA hears input on psychedelics, PDUFA, lung cancer’s next-gen therapies boost survival
September 16, 2026
 · 
1 min read
 · 
Jef Akst
Creative concept of leadership and innovation with a glowing blue light bulb leading paper planes. Symbol of advanced technology, AI-driven strategy, and visionary direction in a digital future.
Regulatory
FDA opens Operation TrialBlazer for applications, hoping to reshore early trials
September 15, 2026
 · 
1 min read
 · 
Heather McKenzie